Calpain-mediated ABCA1 degradation: post-translational regulation of ABCA1 for HDL biogenesis

Area of Science:

• Lipid metabolism
• Cardiovascular research
• Cell biology

Background:

• High-density lipoprotein (HDL) biogenesis is primarily driven by helical apolipoproteins removing cellular lipids via ATP-binding cassette transporter A1 (ABCA1).
• ABCA1 activity is regulated by gene expression and post-translational modifications, including calpain-mediated degradation.
• Endocytosis and subsequent degradation in early endosomes limit ABCA1's availability for HDL biogenesis.

Purpose of the Study:

• To investigate the role of calpain-mediated degradation in regulating ABCA1 activity and HDL biogenesis.
• To explore the potential of inhibiting ABCA1 degradation to enhance HDL formation and suppress atherosclerosis.

Main Methods:

• Studied ABCA1 regulation, including its endocytosis and degradation pathways.
• Investigated the impact of calpain inhibition on ABCA1 activity and HDL biogenesis in vitro and in vivo.
• Examined factors that influence ABCA1 clearance and recycling.

Main Results:

• ABCA1 becomes resistant to calpain degradation during HDL biogenesis, facilitating its recycling to the cell surface.
• Factors like α1-syntrophin, LXRβ, and calmodulin can retard ABCA1 clearance.
• Pharmacological inhibition of calpain-mediated ABCA1 degradation increases ABCA1 activity and HDL biogenesis.

Conclusions:

• ABCA1 recycling to the cell surface is crucial for HDL biogenesis.
• Inhibiting calpain-mediated degradation of ABCA1 represents a potential therapeutic strategy to boost HDL levels and combat atherosclerosis.